Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:16 PM
Ignite Modification Date:
2025-12-24 @ 11:16 PM
NCT ID:
NCT00726856
Eligibility Criteria:
Inclusion Criteria:
* Patient was \> 20 years and \< 75 years of age on the index date\*
* Patient diagnosed with dyslipidemia who did not respond adequately based on NCEP ATP III target to previous lipid lowering treatment, and have received dual inhibition therapy, such as ezetimibe plus statins, ezetimibe plus fenofibrate or ezetimibe alone, for at least 3 months
* Patient has at least one Total Cholesterol and LDL-C measurements at baseline and 3 months after initiating the dual inhibition therapy.
* Patient has the following records documented in the chart during the data collection period:
* Medical history and co morbidities (if available)
* Total Cholesterol and LDL-C. test results before and after initiating the dual inhibition therapy
* Prescription information of lipid-lowering dual inhibition regimens NOTE: \* Index date: the date of initiating dual inhibition therapy
Exclusion Criteria:
* Patients who do not meet all the inclusion criteria will be excluded from this survey.
* Patients who were enrolled in other clinical trial observing specific study procedures which deviates from normal practice will not be included in this study.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
20 Years
Maximum Age:
75 Years
Study:
NCT00726856
Study Brief:
Protocol Section:
NCT00726856